CYTO Share Price Performance
Recent CYTO News & Updates
No updates
Cytophage Technologies Ltd. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.077
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Cytophage Technologies Ltd. Competitors
About CYTO
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name; and water-soluble solution for livestock producers under the FarmPhage name. The company is headquartered in Oak Bluff, Canada.
Canadian Market Performance
- 7 Days: 0.9%
- 3 Months: 11.0%
- 1 Year: 18.4%
- Year to Date: 10.4%
In the last week, the market has been flat, with a notable exception in the Industrials sector dropping 3.1%. Meanwhile, the market is actually up 18% over the past year. Earnings are forecast to grow by 12% annually. Market details ›
The tide is turning for UK & European markets. Index ETFs won’t cut it since sector spreads are massive. Picking the right companies matters now more than ever.
Continue readingLast Week
